Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT06045962

Optimal Stent Duration After Ureteroscopy

Conditions: Ureteral Stent

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 172
Sponsor: Mayo Clinic

Location: Mayo Clinic Arizona Phoenix Arizona

Summary

The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.

Eligibility Criteria

Inclusion Criteria * Participants undergoing unilateral stone treatment. Patients may have stones present bilaterally, but must only be having unilateral intervention. * The ureteroscopy must be uncomplicated * Patients undergoing semi-rigid ureteroscopy only, flexible ureteroscopy only, or a combination Exclusion Criteria * Pregnancy * A stent or nephrostomy tube placed prior to surgery * Complex ureteroscopy - ureteral injury, ureteral perforation, ureteral stricture, impacted stone * Infection or struvite stones * Recurrent Urinary Tract Infection (UTI): 2 culture proven UTI in 6 months or 3 culture proven UTIs in one year * No stone evident on ureteroscopic evaluation of ureter or kidney * Transplant kidney * Variant anatomy (horseshoe, pelvic kidney)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06045962). StuddyBuddy aggregates publicly available trial information.